Coyden

Manufacturer
Huvepharma, Inc. | Huvepharma EOOD
Effective date
2024-05-08
Label type
OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 02:43:04

Label at a glance#

ProductCoyden Type A Medicated Article
Active ingredientCLOPIDOL
Label structure13 sections

Storage and handling

STORE IN A COOL PLACE KEEP BAG TIGHTLY CLOSED

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Approved by the FDA under NADA # 034-393

COYDEN® 25%
(clopidol)
Type A Medicated Article

OTC - ACTIVE INGREDIENT SECTION

ACTIVE DRUG INGREDIENT: Clopidol.................................113.5 gm/lb (25%)

INACTIVE INGREDIENT SECTION

INGREDIENTS: Rice Hulls, Mineral Oil, Fatty Acid Glycerides

INDICATIONS & USAGE SECTION

BROILER/REPLACEMENT CHICKENS:
As an aid in the prevention of cecal and intestinal cocciodiosis caused by E. tenella, E. necatrix,
E. acervulina, E. maxima, E. brunetti, E. mivati.

TURKEYS:
As an aid in the prevention of leucocytozoonosis caused by Leucocytozoon smithi.

SEE DIRECTIONS ON BACK PANEL

FOR THE MANUFACTURE OF COMPLETE FEEDS ONLY.

SPL UNCLASSIFIED SECTION

Manufactured by:
HUVEPHARMA, Inc. Peachtree City, GA 30269      Huvepharma, Inc.
                                                                                     525 Westpark Drive, Suite 230
Distributed by:                                                             Peachtree City, GA 30269
HUVEPHARMA, Inc. Peachtree City, GA 30269

For questions, call 1-877-994-4883

® COYDEN is a registered trademark of Huvepharma, Inc.

Net Wt.: 50 lb (22.68 kg)

INDICATIONS & USAGE SECTION

INDICATIONS FOR USE:
BROILER AND REPLACEMENT CHICKENS
As an aid in the prevention of coccidiosis in broilers and replacements for caged layers caused by
E. tenella, E. necatrix, E. acervulina, E. maxima, E. brunetti, E. mivati.

TURKEYS GROWN FOR MEAT PURPOSES ONLY
As an aid in the prevention of leucocytozoonosis caused by Leucocytozoon smithi.

USER SAFETY WARNINGS SECTION

USER SAFETY WARNING:
Not for Human Use. Keep Out of Reach of Children.
Contact Huvepharma Inc. at 1-877-994-4883 or www.huvepharma.us. For additional
information about reporting side effects for animal drugs, contact FDA at 1-888-FDA-VETS or
www.fda.gov/reportanimalae.

RESIDUE WARNING SECTION

                     WITHDRAWAL PERIODS AND RESIDUE WARNINGS:
CHICKENS: When feeding 0.025% clopidol, reduce dosage to 0.0125% or withdraw
medication 5 days before slaughter. Do not feed to chickens over 16 weeks of age.
TURKEYS: Withdraw medication 5 days before slaughter.

GENERAL PRECAUTIONS SECTION

CAUTION: Consult a veterinarian or poultry pathologist if losses exceed 0.5% in a 2-day period.

DOSAGE & ADMINISTRATION SECTION

MIXING DIRECTIONS:
For Complete Rations - Type C Medicated Products
COYDEN® 25% (clopidol) should be thoroughly and evenly mixed in the feed in accordance with
current good manufacturing practice for medicated feed. COYDEN 25% may be used to manufacture
a Type C medicated feed in the concentration range of 0.0125% to 0.025% clopidol.

To aid in even distribution of COYDEN 25% in the finished feed, prepare a mixture of COYDEN 25% in
a portion of complete feed ingredient before mixing into the finished ration. Blend the mixture with
the remainder of the finished feed and mix thoroughly.

DIRECTIONS FOR USE:
Must be mixed with other ingredients before feeding.
Mixing and conveying equipment should be properly grounded.
Use 1 pound of COYDEN 25% per ton of feed to produce a feed containing 0.0125% clopidol.
Use 2 pounds of COYDEN 25% per ton of feed to produce a feed containing 0.025% clopidol.

FEEDING DIRECTIONS:
Feed continuously, as the sole ration, either the 0.0125% or 0.025% Type C medicated feed
depending upon management practices, degree of exposure, and amount of feed eaten.

STORAGE AND HANDLING SECTION

STORE IN A COOL PLACE
KEEP BAG TIGHTLY CLOSED

USER SAFETY WARNINGS SECTION

Restricted Drug (California)
Use only as Directed

Take TimeTake Time

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Bag LabelBag Label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
23243-9568-5CoydenType A Medicated Article22.68 kg in 1 BAGPOWDER22.685

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
23243-9568COYDEN TYPE A MEDICATED ARTICLE (CLOPIDOL) POWDER [HUVEPHARMA, INC.]51 package rows20240510_28e3ce6c-fb4a-45a9-bd1d-74b1c61005b7.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CLOPIDOLACTIVE INGREDIENT8J763HFF5N1
CLOPIDOLACTIVE MOIETY8J763HFF5N1
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP1
RICE BRANINACTIVE INGREDIENTR60QEP13IC1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
23243-956823243-9568-5

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
CLOPIDOL8J763HFF5NACTIB
MINERAL OILT5L8T28FGPIACT
RICE BRANR60QEP13ICIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 30 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MINERAL OILMINERAL OILT5L8T28FGPGEL / TOPICAL2.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / OPHTHALMIC59.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCAPSULE / ORAL120 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, DELAYED RELEASE / ORAL5.67 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, CHEWABLE / ORAL6 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / TOPICAL9938 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, COATED / ORAL1.5 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSYSTEM / TRANSDERMAL6.09 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPLOTION / TOPICAL1428 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUPPOSITORY / VAGINAL30 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPPASTE / DENTAL95 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, FILM COATED / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUSPENSION / OPHTHALMIC0.1 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSYSTEM / TOPICAL654.36 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPFILM, EXTENDED RELEASE / TRANSDERMAL34 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUPPOSITORY / RECTALNAExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUSPENSION / AURICULAR (OTIC)0.5 %w/vExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCREAM / TOPICAL2772 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSPRAY / TOPICAL1379 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCREAM / VAGINAL402 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOIL / TOPICAL43.29 %v/vExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSOAP / TOPICAL0.82 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / AURICULAR (OTIC)NAExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPPASTE / TOPICAL47.5 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPDROPS / ORALNAExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSUSPENSION / TOPICAL82 %w/wExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPCAPSULE, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPFILM / TRANSDERMAL11.42 mgExact identifier — unii candidate
30 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET / ORAL113.75 mgExact identifier — unii candidate
30 equally ranked IID candidates

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.